Ключевые слова:
Escherichia coli, urogenital infections, antibiotic resistance, urinary tract infection, antibial resistance, biofilm formation, Uropathogenic Escherichia coli, Molecular diagnostics.Библиографические ссылки
Afsharikhah S, Ghanbarpour R, Mohseni P, Adib N, Bagheri M, Jajarmi M. High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran. BMC Microbiol. 2023;23:114. doi:10.1186/s12866-023-02860-7.
Al-Jamei SA, Al Nasser SM, Alomary MN, Alsaif GS, Alharbi AH, Alotaibi FE, et al. antimicrobial resistance patterns of Escherichia coli isolated from urinary tract infections in Saudi Arabia: a multicenter retrospective study. J Infect Public Health. 2022;15(8):803–810. doi:10.1016/j.jiph.2022.05.002.
Al-Momani H, Al-Momani F, Ibrahim NK, et al. Virulence-associated genes and antimicrobial resistance patterns in bacteria isolated from pregnant and nonpregnant women with urinary tract infections: the risk of neonatal sepsis. Infect Dis. 2023;55(6):380–389. doi:10.1080/23744235.2023.37815047.
Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310(6973):170. doi:10.1136/bmj.310.6973.170.
Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. 2nd ed. Cambridge: Cambridge University Press; 2010.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: CLSI; 2020.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro3432.
Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott’s Diagnostic Microbiology. 12th ed. St. Louis: Mosby Elsevier; 2007.
Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott’s Diagnostic Microbiology. 14th ed. St. Louis: Elsevier; 2016.
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13. doi:10.1016/j.idc.2013.09.003.
Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Clin Microbiol Rev. 2022;35(3):e00002-22. doi:10.1128/CMR.00002-22.
García T, López-Cortés A, Salazar E. Statistical analysis in medical research: ANOVA and nonparametric tests. Med Stat J. 2020;12(3):45–56.
Ghumra S, Ambrose A, McCarthy CA, et al. Molecular diagnostic methods versus conventional urine culture for diagnosis and treatment of urinary tract infection: a systematic review and meta-analysis. Clin Infect Dis. 2022;74(9):e1203–e1212. doi:10.1093/cid/ciac655.
Giske CG, Glupczynski Y, Kahlmeter G, et al. Emerging threats: Antimicrobial resistance in extended-spectrum beta-lactamase and carbapenem-resistant Escherichia coli. Lancet Infect Dis. 2023;23(4):e79–e86. doi:10.1016/S1473-3099(23)00075-9.
Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2022;327(10):1020–1031. doi:10.1001/jama.2022.1385.
Gupta K, Bhadelia N, Wullt B, Grigoryan L, Trautner BW. Antibiotic treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Clin Microbiol Rev. 2023;36(1):e00289-22. doi:10.1128/CMR.00289-22.
Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken, NJ: Wiley; 2013.
Hooton TM, Gupta K. Urinary tract infections and asymptomatic bacteriuria in pregnancy. In: Post TW, editor. UpToDate. Waltham, MA: UpToDate; 2012 [updated 2012].
Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: “the other bad E. coli.” J Lab Clin Med. 2018;139(3):155–162. doi:10.1067/mlc.2002.121550.
Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181(1):261–272. doi:10.1086/315217.
Johnson TJ, Wannemuehler Y, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob Agents Chemother. 2020;64(3):e01918-19. doi:10.1128/AAC.01918-19.
Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–1755. doi:10.1086/647952.
Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–140. doi:10.1038/nrmicro818.
Katongole P, Nalubega F, Florence NC, Asiimwe B, Andia I. Biofilm formation, antimicrobial susceptibility and virulence genes of uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infect Dis. 2020;20:453. doi:10.1186/s12879-020-05186-1.
Maheshwari M, Ahmad I, Althubiani AS, Abulreesh HH, Khan MS, Ahmad S. Isolation and molecular characterization of multidrug-resistant uropathogenic Escherichia coli from clinical samples. Saudi J Biol Sci. 2020;27(11):3620–3626. doi:10.1016/j.sjbs.2020.09.028.
Manohar P, Loh B, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary bacterial infections during pulmonary viral disease: pathogenesis, diagnosis, and treatment. Front Microbiol. 2020;11:231. doi:10.3389/fmicb.2020.00231.
Martinez JL, Coque TM, Baquero F. What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol. 2021;19(2):116–130. doi:10.1038/s41579-020-00446-0.
McHugh ML. The chi-square test of independence. Biochem Med (Zagreb). 2013;23(2):143–149. doi:10.11613/BM.2013.018.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–686. doi:10.1128/CMR.18.4.657-686.2005.
Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52–59. doi:10.1093/jac/dki166.
Roberts JA. Etiology and pathophysiology of pyelonephritis. Am J Kidney Dis. 1996;28(6 Suppl 1):S1–S6. doi:10.1016/s0272-6386(96)90134-5.
Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ. Utilization of an intracellular bacterial community pathway in Escherichia coli urinary tract infection. Proc Natl Acad Sci U S A. 2021;118(6):e2019407118. doi:10.1073/pnas.2019407118.
Rossi R, Ricci C, Rocca F, Bazzocchi V, Gualco L, Marchese A. Antimicrobial resistance and virulence profiles of Escherichia coli causing urinary tract infections in Europe: results of a multicenter study. Eur Urol. 2022;81(3):345–354. doi:10.1016/j.eururo.2021.11.004.
Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49(4):543–551. doi:10.1086/600885.
Singh U, Bana RK, Yamuganti VK, Bapat P, Dhanashree B. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 2019;19:158. doi:10.1186/s12866-019-1587-3.
Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa J, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect. 2019;25(1):1034–1036. doi:10.1016/j.cmi.2018.05.012.
Storme O, Tirán-Saucedo J, Garcia-Mora A, Dehesa-Dávila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol. 2019;11:1756287218814382. doi:10.1177/1756287218814382.
Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43(12):5860–5864. doi:10.1128/JCM.43.12.5860-5864.2005.
Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2020;108:104–112. doi:10.1016/j.yexmp.2019.104112.
Zhou Y, Zhang L, Wang X, Chen H, Li J, Liu Y. Correlation between Escherichia coli infection during pregnancy and maternal-fetal outcomes: a retrospective analysis. BMC Infect Dis. 2025;25(1):10998. doi:10.1186/s12879-025-10998-0.